Royce Bedward

General Counsel presso ALCON INC.

58 anni

Health Technology

Consumer Services

Profilo

Royce R.
Bedward is currently working as the Secretary, Senior Vice President & General Counsel at Alcon AG since 2016 and as the General Counsel at Aerie Pharmaceuticals, Inc. since 2022.
Previously, he worked at Hospira, Inc. as the Secretary, Senior Vice President & General Counsel from 2004 to 2015.
Mr. Bedward completed his undergraduate degree at St. Norbert College, Inc. and his graduate degree at the University of Illinois College of Law.

Posizioni attive di Royce Bedward

Società	Posizione	Inizio
ALCON INC.	General Counsel	-
AERIE PHARMACEUTICALS, INC.	General Counsel	21/11/2022

Tutte le posizioni attive di Royce Bedward

Precedenti posizioni note di Royce Bedward

Società	Posizione	Fine
HOSPIRA, INC.	General Counsel	01/09/2015

Vedi nel dettaglio l'esperienza di Royce Bedward

Formazione di Royce Bedward

St. Norbert College, Inc.	Undergraduate Degree
University of Illinois College of Law	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Royce Bedward

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ALCON INC.	Health Technology

Aziende private	2
Hospira, Inc. Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.	Health Technology
Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.	Health Technology

Aziende private